Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...

Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...

The vaccine causes your body to make a small amount of COVID protein, which your body recognizes as foreign and destroys.

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

"We show that if you can see where a virus is evolving ahead of time, you can begin to make future-proof vaccines," said first author Noor Youssef, a scientific lead for the Predictive Modeling for ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

In recent interviews, Health and Human Services Secretary Robert F. Kennedy Jr. has minimized the risk COVID-19 poses to kids ...

The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...

Colleges that require students to undergo a COVID-19 vaccine will have their federal funding ended if House lawmakers get ...